Page URL:

Doubts over stem cell heart treatment

8 March 2004
By BioNews
Appeared in BioNews 248

The use of blood stem cells to treat heart attack patients shows promise, but can lead to complications, South Korean researchers say. A new study published in the Lancet shows that although the experimental treatment can help repair damaged heart tissue, it also causes side effects in many patients. As a result of their findings, the Seoul National University scientists have stopped enrolling people in a stem cell trial. A second study by US researchers, also reported in the Lancet, reports that similar treatment in dogs triggered heart cell death.

There is some evidence that adult stem cells present in the blood and bone marrow can produce other body tissues, as well as different types of blood cells. But it is not known exactly how this happens - it could be that the cells are fusing with existing cells, rather than transforming into them. Some scientists have warned that human trials using blood stem cells to treat damaged tissues should be postponed, until more is known about the processes involved. In the US, the Food and Drug Administration (FDA) has effectively halted such trials, although others are still taking place in other countries. Several groups have already shown in preliminary trials that blood stem cells from bone marrow can successfully repair heart attack damage.

The latest South Korean trial is the first to report using stem cells from blood, rather than bone marrow, which are much more difficult to obtain. The team first injected a chemical called G-CSF (granulocyte-colony stimulating factor), to increase the number of stem cells present in the patients' blood. For ten of the 20 trial participants, the researchers then purified these stem cells, and injected them into the patients' hearts. The scientists found that after six months, seven of those injected with stem cells were able to run further on a treadmill compared to untreated heart attack patients, while three of those treated with G-CSF alone showed no improvement.

But while the stem cell injections appeared to successfully treat the heart damage, the use of G-CSF triggered an unexpected side effect in five of the seven stem cell group, and two of the three G-CSF-only group. All seven developed in-stent restenosis: a narrowing of the coronary artery, despite the prior implantation of tubes (stents) designed to keep the arteries open. The researchers conclude that 'despite the favourable effects on cardiac function, our data warrant a more cautious approach to stem cell therapy, in view of the possible aggravation of restenosis'. However, other scientists caution that the South Korean trial involved a small number of patients, and that the problems might be avoided by adjusting the method.

Meanwhile, a group of researchers at the University of California Davis School of Veterinary Medicine injected bone marrow stem cells into the hearts of healthy dogs. The experiment was designed to investigate the safety of this approach. They found that the treatment caused tiny pockets of cell death, known as micro infarcts, which they describe as 'a surprise finding'. Lead author Dr P.Richard Vulliet said: 'We were giving one dose of stem cells, in the range of what is being done in humans'. The group, who will present their results at a stem cell meeting in Washington later this month, say they are continuing with the studies using a lower dose of stem cells.

Heart therapy raises hopes and concerns
Nature |  5 March 2004
Is it MAGIC?
The Lancet |  6 March 2004
Risks found in stem cell therapy for heart
HealthDay News |  4 March 2004
Stem cell heart repair 'doubts'
BBC News Online |  3 March 2004
18 February 2013 - by Reuben Harwood 
What would be the first clinical trial to use induced pluripotent stem cells has been granted ethical approval in Japan...
29 January 2007 - by Heidi Nicholl 
New research has been published confirming that 'multipotent' adult progenitor cells' (MAPCs), a type of adult stem cell, can repair and restore damaged blood systems in mice. Catherine Verfaillie and colleagues at the University of Minnesota first described these novel stem cells in 2002, but other teams...
4 February 2005 - by BioNews 
A new type of stem cell isolated from human bone marrow could have all the medical potential of embryonic stem (ES) cells, US researchers say. However, not all scientists are convinced of that the cells are as versatile as they appear to be, according to a report in the Washington...
10 May 2004 - by BioNews 
A new US study calls into question the existence of adult stem cells capable of transforming into insulin-producing pancreatic cells. Previous research in mice has suggested that such cells could be used to develop new treatments for diabetes. But the new study, carried out by scientists at Harvard University in...
29 April 2004 - by BioNews 
Patients with heart failure could one day be treated with injections of their own stem cells, according to new US trials that provide the 'first convincing evidence' that such an approach might work. Previous studies have produced conflicting results, and some researchers have questioned whether stem cell therapies for failing...
20 October 2003 - by BioNews 
Adult bone marrow stem cells fuse with existing cells to grow new tissues, rather than transforming into other types of cell, two new studies suggest. Researchers at Stanford University have shown that transplanted bone marrow cells fuse with specialised brain cells involved in controlling movement and balance. A second study...
11 August 2003 - by BioNews 
Stem cells modified with a 'survival gene' could be used to treat heart attack patients, according to new research carried out on rats. Earlier studies using stem cells to treat heart damage in mice showed promise, but the transplanted cells did not live very long. However, US researchers have now...
28 April 2003 - by BioNews 
Scientists have discovered that injections of (adult) stem cells taken from patient's own bone marrow can be used to help them recover from heart failure. The technique was tested on 21 people with so-called 'end stage' heart failure, and it was found that the health of 13 of those was...
10 March 2003 - by BioNews 
American doctors have used blood stem cells to attempt to repair cardiac muscle damage caused by a heart attack. A 16 year old boy, Dimitri Bonnville, was shot in the heart by a nail gun in early February. Because of the swelling from the injury, he suffered a heart attack...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.